These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17255781)

  • 1. Sarcomatoid breast tumors have sarcomatoid behavior.
    Gilcrease MZ
    Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Micrometastases of the axillary lymph nodes in breast cancer. An immunohistochemical study].
    Ronay G; Tomesch A; Tulusan AH
    Pathologe; 1989 Sep; 10(5):289-93. PubMed ID: 2477837
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal-like subtype breast cancers in women older than 40 years of age.
    Erşahin C; Chivukula M; Bhargava R; Dabbs DJ
    Int J Surg Pathol; 2010 Feb; 18(1):42-7. PubMed ID: 19372082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unifocal intranodal Langerhans' cell histiocytosis associated with metastatic breast carcinoma.
    Cina SJ; Askin FB
    Arch Pathol Lab Med; 1996 Dec; 120(12):1085. PubMed ID: 15456171
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 7. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
    Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
    Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymph node metastasis of a "squamous cell carcinoma" as a manifestation of occult breast cancer].
    Ronay G; Zimmermann HD; Tulusan AH
    Pathologe; 1988 Sep; 9(5):309-12. PubMed ID: 2845387
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
    Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
    Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast.
    Looi LM; Cheah PL; Zhao W; Ng MH; Yip CH
    Malays J Pathol; 2006 Dec; 28(2):83-6. PubMed ID: 18376796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis.
    Zavyalova MV; Perelmuter VM; Vtorushin SV; Denisov EV; Litvyakov NV; Slonimskaya EM; Cherdyntseva NV
    Diagn Cytopathol; 2013 Mar; 41(3):279-82. PubMed ID: 22102485
    [No Abstract]   [Full Text] [Related]  

  • 13. Is breast tumor progression really linear?
    Polyak K
    Clin Cancer Res; 2008 Jan; 14(2):339-41. PubMed ID: 18223205
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two score systems in Bcl-2 and Bax protein expression in invasive ductal carcinoma of breast and relation with oestrogen and progestrone receptors.
    Ayatollahi H; Ghaffarzadegan K; Sharifi N; Farahmand MJ; Jarafian AH
    Breast J; 2009; 15(3):310-2. PubMed ID: 19645793
    [No Abstract]   [Full Text] [Related]  

  • 16. Metastatic mammary carcinoma with DCIS-like morphology: a report of two cases.
    Coyne J
    Int J Surg Pathol; 2012 Oct; 20(5):485-7. PubMed ID: 22297833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of interleukin-10 in sentinel lymph node with breast cancer.
    Woo SU; Bae JW; Yang JH; Kim JH; Nam SJ; Shin YK
    Ann Surg Oncol; 2007 Nov; 14(11):3268-73. PubMed ID: 17762971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness.
    Man YG; Schwartz A; Levine PH; Teal C; Berg PE
    Cancer Biomark; 2009; 5(1):9-17. PubMed ID: 19242057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry to detect sentinel nodal metastases in mammary lobular carcinoma.
    Cserni G
    Hum Pathol; 2009 Mar; 40(3):441; author reply 442. PubMed ID: 19200488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal breast cancers: histological and immunohistological findings].
    Horny HP; Horst HA
    Verh Dtsch Ges Pathol; 1985; 69():331-7. PubMed ID: 3006384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.